Introduction {#s1}
============

High-affinity and long-lasting humoral immunity against infection requires controlled cross-talk between limiting CD4^+^CXCR5^high^PD1^high^BCL6^high^ T follicular helper (Tfh) cells and immunoglobulin-maturing germinal center (GC) B cells in secondary lymphoid tissues ([@bib41]; [@bib86]; [@bib63]; [@bib69]). As the GC largely consists of clonally diverse B cells, Tfh cells especially in narrow numbers are best at maintaining a selective pressure for B cell competition, favoring the survival of greater affinity antigen-responsive GC B cell clones ([@bib68]; [@bib85]). Deregulation of Tfh cells can lead to faulty GC selection that may also seed the production of autoantibodies ([@bib90]; [@bib87]; [@bib39]; [@bib50]) and GC-derived malignancies such as follicular lymphoma ([@bib70]; [@bib42]). To date, the signals that exclusively govern Tfh cell differentiation over other T cell effector subsets remains poorly characterized.

ROQUIN (also called ROQUIN1; encoded by *Rc3h1*) acts to post-transcriptionally repress Tfh cells by binding effector T cell transcripts via its winged-helix ROQ domain ([@bib74]; [@bib83]; [@bib73]) and recruiting proteins of the RNA decapping and deadenylation machinery ([@bib3]; [@bib24]; [@bib45]; [@bib67]; [@bib92]; [@bib88]) as well as the endoribonuclease REGNASE-1 ([@bib31]). Some of its RNA targets include the Tfh-polarising *Icos* ([@bib24]) and *Il6* mRNA ([@bib31]) as well as *Ox40* ([@bib88]) and *Tnf* ([@bib67]) transcripts. In *sanroque* mice, an *Rc3h1* missense point mutation, encoding for a Met^199^ to Arg substitution translates into a minor conformational shift in the RNA-binding ROQ domain ([@bib78]) of ROQUIN and a loss of function in post-transcriptional repression. This leads to excessive Tfh growth and systemic autoimmunity ([@bib50]; [@bib87]). Complete ablation of ROQUIN results in unexplained perinatal lethality in C57BL/6 mice and selective deletion of ROQUIN in T cells does not lead to Tfh cell accumulation nor autoimmunity ([@bib5]). The latter is at least in part explained by the existence of the closely related family member ROQUIN2 (encoded by *Rc3h2*), which has overlapping functions with ROQUIN ([@bib67]; [@bib88]). The ROQUIN^M199R^ mutant protein has been proposed to act as a 'niche-filling' variant that has lost its RNA-regulating activity ([@bib67]) but can still localize to mRNA-regulating cytoplasmic granules to prevent the compensatory activity of ROQUIN2.

ROQUIN contains a conserved amino terminal RING finger with two conforming zinc-chelating sites ([@bib78]), despite an atypical aspartate as its eighth zinc ligand synonymous to RBX1 ([@bib35]). This suggests ROQUIN may function as an E3 ubiquitin ligase ([@bib15]) but, to date, no such enzymatic activity of the ROQUIN RING domain has been demonstrated in mammals. *In vivo* attempts to delineate the cellular pathways regulated by ROQUIN are made challenging due to the existence of multiple protein domains in the protein ([Figure 1---figure supplement 1a](#fig1s1){ref-type="fig"}). The *Caenorhabditis elegans* ROQUIN ortholog, RLE-1, acts through its RING domain to ubiquitinate DAF-16, a pro-longevity forkhead box O (FOXO) transcription factor homolog ([@bib47]). We did not find any evidence for molecular binding between ROQUIN and the fruitfly or mammalian FOXO orthologs (*Drosophila melanogaster* FOXO and *Mus musculus* FOXO1 or FOXO3a; data not shown) and therefore set out to understand the role of ROQUIN RING signaling in CD4^+^ T cell development and function by generating mice that selectively lack the ROQUIN RING zinc finger.

We previously demonstrated that ROQUIN RING-deleted T cells in mice 6 days after sheep red blood cell (SRBC) immunization can form normal early Tfh cell responses but fail to promote optimal GC B cell reactions ([@bib67]). Here, in mice that have developed robust Tfh-dependent GC responses toward SRBC or infected with lymphocytic choriomeningitis virus (LCMV), we identify a novel and unexpected role of the ROQUIN RING domain in selectively promoting mature antigen-specific Tfh cell responses while leaving unaffected the development of other CD4^+^ effector T cell lineages. ROQUIN directly binds to and limits adenosine monophosphate-activated protein kinase (AMPK), a tumor suppressor and central regulator of T cell glucose uptake and glycolysis ([@bib53]). Our data indicate that loss of AMPK repression by deletion of the ROQUIN RING domain promotes stress granule persistence. This in turn cripples mTOR activity, otherwise known to play a critical role in driving CD4^+^ effector T cell expansion ([@bib13]; [@bib14]) and T-dependent antibody responses ([@bib37]; [@bib94]; [@bib23]; [@bib11]).

Results {#s2}
=======

The ROQUIN RING domain selectively controls Tfh cell formation {#s2-1}
--------------------------------------------------------------

To examine the function of the ROQUIN RING domain *in vivo*, we generated two strains of C57BL/6 mice carrying either a germline deletion (designated *ringless*; '*rin'* allele) or a T cell conditional deletion (*Tringless*; '*Trin'* allele) of exon 2 in the *Rc3h1* gene, which encodes the translation START codon and RING finger domain of the ROQUIN protein ([Figure 1---figure supplement 1b, c](#fig1s1){ref-type="fig"} and [@bib67]). In these mice, skipping of exon 2 resulted in splicing of exon 1 to exon 3 yielding an alternative in-frame Kozak translation initiation site at Met^133^ ([Figure 1---figure supplement 1d, e](#fig1s1){ref-type="fig"}). This predicted ROQUIN^133-1130^ protein product specifically lacks the RING domain ([Figure 1---figure supplement 1f](#fig1s1){ref-type="fig"}). Mice homozygous for the *rin* allele were perinatally lethal ([Figure 1---figure supplement 1g--i](#fig1s1){ref-type="fig"}), precluding T cell studies in intact animals. In contrast, *Tringless* mice were viable and showed no severe variations in thymic development and output of CD4 single positive T cells ([Figure 1---figure supplement 2a--e](#fig1s2){ref-type="fig"}). There were also no major changes in Th1 cell differentiation in *Tringless* mice infected with LCMV ([Figure 1a](#fig1){ref-type="fig"}), which predominantly yields LY6C^high^ Th1 and LY6C^low^ Tfh virus-specific effector cells ([@bib26]; [@bib56]). In *Tringless* animals immunized with SRBCs, the formation of Th1, Th2, Th17, and regulatory T cells also remained largely unperturbed ([Figure 1---figure supplement 2f, g](#fig1s2){ref-type="fig"}). This was mirrored *in vitro* with *Tringless* CD4^+^ naive T cells activated under Th1, Th2, Th17, or induced Treg (iTreg) polarizing conditions ([Figure 1---figure supplement 2h](#fig1s2){ref-type="fig"}) displaying maximal expression of intracellular TBET, GATA3, RORγT, and FOXP3 comparable to floxed wild-type T cell cultures ([Figure 1---figure supplement 2i](#fig1s2){ref-type="fig"}). Surprisingly in *Tringless* mice, there was an overall defective Tfh cell primary response to LCMV infection ([Figure 1b--d](#fig1){ref-type="fig"}) and to SBRC immunization ([Figure 1---figure supplement 3a](#fig1s3){ref-type="fig"}). ROQUIN RING-deficient T cells were also inefficient in supporting GC formation ([Figure 1e, f](#fig1){ref-type="fig"} and [Figure 1---figure supplement 3b](#fig1s3){ref-type="fig"}), which was associated with reduced IL-21 production ([Figure 2a](#fig2){ref-type="fig"}), a Tfh signature cytokine vital in supporting GC reactions ([@bib52]).10.7554/eLife.08698.003Figure 1.ROQUIN RING deletion in T cells preferentially controls Tfh cell formation.(**a-f**) Flow cytometric examination of mice d10 post-LCMV infection. (**a**) Proportion of LY6C^+^ total Th1 cells from CD4^+^CD44^high^ T cells. (**b**) Identification of total Tfh cells pre-gated on CD4^+^CD44 ^high^ T cells. (**c**) Proportion of PD1^high^CXCR5^high^ Tfh cells from CD4^+^CD44^high^ T cells. (**d**) PD1^high^CXCR5^high^CD44 ^high^ Tfh cell numbers from spleen. (**e**) Proportion and (**f**) cell count of GL7 ^high^FAS^high^ GC B cells in spleen. Data are pooled from three independent experiments (n = 2--3). Statistics were calculated by Student's t-test, n.s., not significant; \**p*\<0.05; \*\**p*\<0.005. Dot symbols, individual mice; columns, median.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.003](10.7554/eLife.08698.003)10.7554/eLife.08698.004Figure 1---figure supplement 1.Generation of mice with a ROQUIN RING deletion.(**a**) Secondary structure of mammalian ROQUIN protein. (**b**) Generation of *ringless* or *Tringless* mice with a deletion of *Rc3h1* exon 2 when crossed to *Rosa*:Cre or *Lck*:Cre transgenic strains, respectively. White boxes, non-coding exons; black boxes, protein encoding exons; Neo^R^, Neomycin resistance cassette. (**c,d**) Deletion of *Rc3h1* exon 2 detected in CD4^+^ T cells by Polymerase chain reaction (PCR; **c**) and sequencing (**d**) from cDNA. (**e**) Alignment of the mammalian Kozak sequence and alternative translational start site at Met^133^ in *Rc3h1^ringless^*. Solid lines, identical; dotted lines, similar. (**f**) ROQUIN protein map lacking the 14.5 kDa RING finger with translational rescue at Met^133^. (**g,h**) Wild-type (left) *ringless* (right) embryos harvested at E14 (**g**) and E19 (**h**) from timed matings between *ringless* heterozygotes. (**i**) Embryonic genotyping and litter count from *ringless* heterozygous intercrosses (n = 100 per time point). Statistics were calculated by Chi-square test, d.f. = 2 (**j**) Periodic acid-Schiff staining of the thoracic diaphragm from preterm animals taken at E19. Wild-type (left) and *ringless* (right) are shown. Data are representative of two independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.004](10.7554/eLife.08698.004)10.7554/eLife.08698.005Figure 1---figure supplement 2.Phenotype of mice with a T cell-specific ROQUIN RING deletion.(**a-e**) Flow cytometric assessment of thymocyte development showing proportion of single positive (SP) CD4 and SP CD8 thymocytes (**a**), total number of SP CD4 thymocytes (**b**), proportion and count of FOXP3^+^CD25^+^ thymic regulatory T cells (tTreg) from SP CD4 thymocytes (**c**), surface expression TCRβ on SP CD4 thymocytes (**d**), and cell number of peripheral CD4^+^ T cell output in the spleen (**e). (f,g**) d8 post-sheep red blood cell (SRBC) immunization of mice showing the proportion of IFNγ^+^ Th1, IL4^+^ Th2, and IL-17^+^ Th17 cells (**f**), and the proportion of FOXP3^+^CD25^+^ Tregs (**g**) from splenic total CD4^+^ T cells. Data are representative of four independent experiments. (**h-i**) *In vitro* CD4^+^ T cell differentiation assay on naive T cells cultured under Th1, Th2, Th17, or iTreg-polarizing conditions and analyzed d3 by flow cytometry (**h**) to measure expression of Th cell transcription factors in CD25^+^CD69^+^ activated T cells and on FOXP3^+^ activated T cells for iTreg cultures (**i**). Statistics were calculated by Student's t-test, n.s., not significant; Dot symbols, individual mice; columns, median.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.005](10.7554/eLife.08698.005)10.7554/eLife.08698.006Figure 1---figure supplement 3.Phenotype of SRBC-immunized mice with a T cell-specific ROQUIN RING deletion.(**a-c**) Flow cytometric analysis of d8 post-sheep red blood cell (SRBC) immunized mice showing the frequency of PD1^high^CXCR5^high^ Tfh cells from total CD4^+^ T cells (**a**), GL7^high^FAS^high^ germinal center (GC) B cells from total B220^+^ B cells in the spleen (**b**) compared to phosphate-buffered saline (PBS) injected control animals. Data are representative of four independent experiments. Statistics were calculated by Student's t-test, \**p* \<0.05; Dot symbols, individual mice; columns, median.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.006](10.7554/eLife.08698.006)10.7554/eLife.08698.007Figure 2.Functional competency of ROQUIN RING deleted Tfh cell responses.(**a**) Flow cytometric analysis of mice 8d after sheep red blood cell (SRBC) immunization showing the proportion of IL-21^+^CD44^high^ effectors from total CD4^+^ T cells in the spleen. Data are representative of two independent experiments. (**b-i**) Flow cytometric examination of mice d10 post-lymphocytic choriomeningitis virus (LCMV) infection. (**b**) Proportion of IFNγ^+^ Th1 cells gated from total CD4^+^ T cells after GP~61-80~ peptide stimulation *ex vivo*. (**c**) Proportion of LY6C^+^ Th1 cells from virus-specific CD4^+^GP~66-77~^+^ T cells. (**d**) Identification of virus-specific Tfh cells pre-gated on CD4^+^GP~66-77~^+^ T cells. (**e**) Proportion of PD1^high^CXCR5^high^ Tfh cells from virus-specific CD4^+^GP~66-77~^+^ T cells. (**f**) Virus-specific CD4^+^PD1^high^CXCR5^high^GP~66-77~^+^ Tfh cell numbers in spleen. (**g**) Representative histograms of BCL6 expression in virus-specific CD4^+^GP~66-77~^+^ T cells. Values included show median MFI for each genotype. (**h**) Proportion of FOXP3^+^ Tfr cells within the total CD4^+^CD44^high^PD1^high^CXCR5^high^ Tfh gate. (**i**) Proportion of FOXP3^+^ Tfr cells within the virus-specific CD4^+^GP~66-77~^+^PD1^high^CXCR5^high^ Tfh gate. Data are pooled from three independent experiments (n = 2--3). Statistics were calculated by Student's t-test, n.s., not significant; \**p*\<0.05; \*\**p*\<0.005; Dot symbols, individual mice; columns, median. **DOI:** [http://dx.doi.org/10.7554/eLife.08698.007](10.7554/eLife.08698.007)

By stimulating splenocytes *ex vivo* with GP~61-80~ peptide to identify virus-responsive IFNγ-producing Th1 cells ([Figure 2b](#fig2){ref-type="fig"}) and by examining splenic LYC6^high^ Th1 cells amongst GP~66-77~^+^ tetramer stained T cells ([Figure 2c](#fig2){ref-type="fig"}), we verified that ROQUIN RING loss did not disrupt protective Th1 responses but caused a severe abrogation of virus-specific Tfh cells during LCMV infection ([Figure 2d--f](#fig2){ref-type="fig"}). Virus-specific T cells also showed significantly reduced expression of BCL6 ([Figure 2g](#fig2){ref-type="fig"}), an indispensible nuclear factor for Tfh cell terminal differentiation ([@bib52]). Furthermore, we found an increased frequency of FOXP3^+^ T follicular regulatory (Tfr) cells within the total Tfh pool ([Figure 2h](#fig2){ref-type="fig"}) despite these Tfr cells not expressing a GP~66-77~ virus-specific T cell antigen receptor (TCR; [Figure 2i](#fig2){ref-type="fig"}). Nonetheless, as Tfr cells are negative regulators of GC reactions ([@bib69]), their abundance may indicate augmented suppression of Tfh cells and long-term B cell responses.

ROQUIN undergoes RING-dependent autoubiquitination and directly limits AMPK activity {#s2-2}
------------------------------------------------------------------------------------

We next sought to determine the molecular basis for the ROQUIN RING domain as a determinant in protective Tfh cell responses. Several lines of evidence implicated an involvement of ROQUIN in the negative regulation of AMPK signaling: *Rc3h1^ringless^* fetuses displayed skeletal muscle atrophy of the thoracic diaphragm ([Figure 1---figure supplement 1j](#fig1s1){ref-type="fig"}), which is a characteristic phenotype of mice with overactive AMPK ([@bib72]) and pointed to perinatal respiratory failure as the cause of the lethality. Also, AMPK over-expression in nematode worms has been shown to extend lifespan ([@bib55]), an observation consistent with the phenotype of worms lacking the ROQUIN ortholog RLE-1 ([@bib47]). Since the AMPKα1 catalytic subunit is expressed in T cells and responds to TCR activation ([@bib82]), we tested the possibility of ROQUIN directly binding to this subunit of AMPK (encoded by *Prkaa1*). Upon ectopic expression in HEK293T cells, ROQUIN colocalized with AMPKα1 diffusely or in fine cytoplasmic speckles in resting cells and within larger cytoplasmic granules upon induction of oxidative stress ([Figure 3a](#fig3){ref-type="fig"}). We also observed colocalization of endogenous AMPKα1 within ROQUIN^+^ cytoplasmic granules in arsenite-treated primary C57BL/6 mouse embryonic fibroblasts (MEFs) ([Figure 3b](#fig3){ref-type="fig"}) with the use of an AMPKα1-specific antibody displaying no cross-reactivity toward the AMPKα2 subunit when ectopically expressed in HEK293T cells ([Figure 3---figure supplement 1a](#fig3s1){ref-type="fig"}). Unlike the AMPKα1 subunit, ectopically expressed AMPK β and γ regulatory subunits did not associate with ROQUIN^+^ cytoplasmic granules, although AMPKγ2 and AMPKγ3 exhibited generally diffuse cytoplasmic distribution ([Figure 3---figure supplement 1b](#fig3s1){ref-type="fig"}). We next determined if ROQUIN and AMPKα1 interacted by conducting *in situ* proximity ligation assays (PLAs) on primary C57BL/6 MEFs. Compared to control PLAs accounting for false interactions between endogenous AMPKα1 and non-expressed green fluorescent protein (GFP) detected by optimized anti-GFP immunostaining ([Figure 3---figure supplement 1c](#fig3s1){ref-type="fig"}), we found that endogenously expressed ROQUIN and AMPKα1 proteins localized with very close molecular proximity in both resting and arsenite-stressed cells ([Figure 3c, d](#fig3){ref-type="fig"}) at a frequency 15-fold higher or more than weak PLA interactions previously observed between ROQUIN and AGO2 ([@bib78]). Moreover, we were able to coimmunoprecipitate ROQUIN and AMPKα1 when over-expressed in HEK293T cells ([Figure 3---figure supplement 1d](#fig3s1){ref-type="fig"}) or expressed endogenously in the mouse T lymphoblast line EL4 cells ([Figure 3e](#fig3){ref-type="fig"}). Together with the PLAs, this indicated that ROQUIN bound specifically with the α1 subunit of AMPK and that under physiological conditions, the two proteins could form a stable complex.10.7554/eLife.08698.008Figure 3.ROQUIN preferentially colocalizes and binds with the α1 subunit of AMPK.(**a**) Colocalization of V5-ROQUIN and AMPKα1-GFP ectopically expressed in resting (top) and 1 mM arsenite (AS)-treated (bottom) HEK293T cells. Representative of three independent experiments. (**b**) Colocalization of endogenous ROQUIN and AMPKα1 in primary (mouse embryonic fibroblasts) MEFs post-arsenite (AS) treatment. Representative of three independent experiments. (**c**) Proximity ligation assays (PLAs) performed on primary C57BL/6 MEFs showing interactions between endogenously expressed ROQUIN and AMPKα1 in resting cells (ROQUIN:AMPKα1) and in cells stressed with 1 mM arsenite (+AS, ROQUIN:AMPKα1). Negative control PLAs (GFP:AMPKα1) detecting non-expressed GFP and endogenous AMPKα1 background are also displayed. Blue, DAPI stained nuclei; Red, ligation events, Scale bar, 20 μm. Representative of three independent experiments. (**d**) Quantitative analysis of PLAs showing mean ligation events per cell (nucleus) for each field of view on a confocal microscope. Individual dots represent a single field of view; bar per column represents the sample mean. Statistics were calculated by one-way ANOVA with Bonferroni's multiple comparisons test after log transformation of ratio values, n.s., not significant; \*\*\**p*\<0.0005. (**e**) Reciprocal coimmunoprecipitation of ROQUIN and AMPKα1 endogenously expressed in EL4 cells. IB, immunoblot; IP, immunoprecipitated.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.008](10.7554/eLife.08698.008)10.7554/eLife.08698.009Figure 3---figure supplement 1.Association of AMPK subunits with ROQUIN.(**a**) Detection of AMPKα1 by immunostaining primary MEFs (as shown in main [Figure 3b](#fig3){ref-type="fig"}) was achieved using an α1 isoform-specific immunofluorescence-grade antibody exhibiting no cross-reactivity with AMPKα2-GFP expressed in HEK293T cells. (**b**) Protein localization of V5-ROQUIN and carboxy terminal GFP fusion constructs of AMPK regulatory subunits ectopically expressed in HEK293T cells and analyzed by immunofluorescence microscopy. Data are representative of two independent experiments. (**c**) Detection of negative control PLAs (GFP:AMPKα1; as shown in main [Figure 3c](#fig3){ref-type="fig"}) was achieved using anti-GFP antibody titrated by immunostaining transfected HEK293T cells expressing AMPKα1-GFP fusion protein. Blue, DAPI-stained nuclei; Red, anti-GFP stain; Green, anti-AMPKα1 stain; Scale bar, 50 μm. (**d**) Reciprocal coimmunoprecipitation of V5-ROQUIN and AMPKα1-GFP over-expressed in HEK293T cells. Data are representative of four independent experiments. IB, immunoblot; IP, immunoprecipitated.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.009](10.7554/eLife.08698.009)

To determine the functional consequence of a ROQUIN--AMPKα1 interaction, we measured AMPK activity in *Tringless* and wild-type T cells. In contrast to wild-type cells, phosphorylation of the AMPK target, acetyl CoA carboxylase (ACC) in ROQUIN RING-deficient CD4^+^ T cells was increased, demonstrating constitutively active AMPK activity *in vitro* ([Figure 4a](#fig4){ref-type="fig"}) and *in vivo* ([Figure 4b](#fig4){ref-type="fig"}). Thus, ROQUIN acts through its RING domain to directly negatively regulate AMPKα1 activity in T cells.10.7554/eLife.08698.010Figure 4.The ROQUIN RING finger is required for autoubiquitination and negative regulation of AMPK.(**a**) *In vitro* kinase assay of AMPKα in isolated CD4^+^ T cells during an anti-CD3 and -CD28 activation time-course. Data are pooled from two independent experiments and normalized to unstimulated wild-type (n = 5). Black columns, *floxed* wild-type; white columns, *Tringless*. Statistics were calculated by Student's t-test, \**p*\<0.05. †*p* \<0.05 for wild-type at 10 min vs. wild-type at 0 and 5 min. columns, mean; error bars, s.e.m. (**b**) Phospho-blot of endogenous ACC Ser^79^ in resting CD4^+^ T cells. Representative of three independent experiments. IB, Immunoblot. (**c**) Ubiquitin immunobDot of endogenous ROQUIN immunoprecipated from EL4 cells (**d**) Immunoblot of V5-tagged ROQUIN^1-1130^ and ROQUIN^133-1130^ in transfected HEK293T cells (left), endogenous ROQUIN in *ringless* primary MEFs (center), immunoprecipitated ROQUIN in *Tringless* thymocytes (right). (**e**) *In vitro* autoubiquitination assay for ROQUIN wild-type peptide (residues 1--484) and RING finger deleted peptide (residues 145--484). Five consecutive lanes show the extent of ROQUIN autoubiquitination of the same *in vitro* reaction at 0, 1, 2, 4, and 16 h. (**f**) Cellular ubiquitination assay for full length V5-ROQUIN and RING-deleted V5-ROQUIN^133-1130^ ectopically expressed in HEK293T cells with HA-Ub. Data are representative of three independent experiments. IB, immunoblot; IP, immunoprecipitated.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.010](10.7554/eLife.08698.010)

Given the important role of RING domains in driving protein substrate ubiquitination ([@bib15]), we next tested if the regulation of AMPK activity by ROQUIN was a result of RING-mediated AMPK ubiquitination. Absence of the ROQUIN RING domain did not alter AMPK ubiquitination (data not shown). However, monoubiquitination of endogenous ROQUIN in EL4 cells was detected ([Figure 4c](#fig4){ref-type="fig"}). To determine if ROQUIN monoubiquitination was dependent on the 14.7 kDa RING finger deleted in ROQUIN RING deficient mice ([Figure 4d](#fig4){ref-type="fig"}), we tested if ROQUIN could undergo automonoubiquitination *in vitro* and in a cell-based ubiquitin assay. By Coomassie staining PAGE-separated peptides of *in vitro* ubiquitination reactions, we detected a single protein band having higher molecular weight relative to ROQUIN peptide that formed in the presence of wild-type ROQUIN^1-484^ and ubiquitin ([Figure 4e](#fig4){ref-type="fig"}). This slowly migrating band, consistent with monoubiquitin attachment, formed at severely delayed times in the absence of the RING zinc finger. A complete absence of this higher molecular weight ROQUIN peptide modification was observed with *in vitro* reactions lacking ubiquitin protein. We also performed ubiquitination assays in transfected HEK293T cells and detected ubiquitin-conjugated ROQUIN by immunoprecipitation when full-length ROQUIN was over-expressed but not with expression of the ROQUIN^133-1130^ variant recapitulating the specific RING deletion borne by *Tringless* T cells ([Figure 4f](#fig4){ref-type="fig"}). Together, our data show that the ROQUIN RING domain can facilitate automonoubiquitination independent of residues carboxy terminal to Asp^484^.

We next investigated the mechanism by which ROQUIN RING activity limits AMPK signaling. Analogous to RAPTOR inactivation within stress granules ([@bib84]; [@bib91]), we hypothesized that ROQUIN localization and its ability to bind AMPK within stress granules was key to AMPK repression. We have previously shown that ROQUIN^133-1130^ lacking the RING domain did not coalesce with eIF3^+^ stress granules ([@bib67]). To exclude the possibility that this mislocalization of RING-deficient ROQUIN was a product of over-active AMPK feedback, we investigated if AMPK hyperactivity prevented ROQUIN localizing to stress granules. Full length ROQUIN still colocalized with eIF3^+^ stress granules in the presence of the AMPK agonist, AICAR ([Figure 5a](#fig5){ref-type="fig"}), which alone was ineffective at inducing stress granule formation (data not shown). This indicates that ROQUIN^133-1130^ mislocalization is a direct consequence of an intrinsic lack of the RING domain. To confirm that stress granule exclusion was not a secondary effect of a structurally unstable ROQUIN^1-132^ deletion but rather a consequence of the loss of RING-mediated E3 ligase activity, a loss-of-function mutation of the first zinc-coordinating cysteine of the RING domain (Cys^14^Ala; [Figure 5b](#fig5){ref-type="fig"}) that typically abolishes E3 ligase activity of related RING-containing enzymes ([@bib18]; [@bib19]) was introduced into HEK293T cells. Although ROQUIN^C14A^ ectopic expression could facilitate *de novo* stress granule induction in the absence of arsenite treatment comparable to cells transfected with wild-type ROQUIN ([@bib3]), we found that in response to arsenite exposure, ROQUIN^C14A^ localization to eIF3^+^ stress granules was significantly impaired ([Figure 5c](#fig5){ref-type="fig"}). A deleted RING domain did not abrogate ROQUIN^133-1130^-AMPKα1 colocalization; the two proteins were detected in small aggregates most likely outside of stress granules ([Figure 5d](#fig5){ref-type="fig"}). This was consistent with RING deficient ROQUIN^133-1130^ protein still capable of directly binding AMPKα1 ([Figure 5e](#fig5){ref-type="fig"}). Together these findings indicate that ROQUIN RING signaling does not play a role in AMPK recruitment to ROQUIN but rather directs negative regulation of AMPKα1 through sequestration into stress granules following ROQUIN--AMPKα1 complex formation.10.7554/eLife.08698.011Figure 5.ROQUIN RING activity controls its localization to stress granules.(**a**) Colocalization of over-expressed full length V5-tagged ROQUIN or ROQUIN^133-1130^ with endogenous eIF3 in HEK293T cells stressed with 1 mM arsenite (AS) for 1 hr with or without 2 mM AICAR. Scale bar, 50 μm. (**b**) Crystal structure of ROQUIN peptide showing amino terminal residues 6 to 75 incorporating the RING domain. Black, zinc cation; green, zinc-coordinating residue, red, zinc-coordinating Cys^14^ targeted for mutagenesis; yellow, zinc-chelating interaction. Data are based on structural coordinates we had previously determined ([@bib78]) and deposited in the Protein Data Bank, accession code 4TXA. (**c**) Colocalization of over-expressed full length GFP-tagged ROQUIN or ROQUIN^C14A^ mutant with endogenous eIF3 in HEK293T cells stressed with 1 mM arsenite for 1 hr. (**d**) Colocalization of ROQUIN^133-1130^ with AMPKα1 when over-expressed in HEK293T cells immediately after 1 mM arsenite exposure for 1 hr. (**e**) Reciprocal coimmunoprecipitation of full length ROQUIN or ROQUIN^133-1130^ and AMPKα1 over-expressed in HEK293T cells. IB, immunoblot; IP, immunoprecipitated.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.011](10.7554/eLife.08698.011)

ROQUIN RING loss results in stress granule longevity and dampened mTOR {#s2-3}
----------------------------------------------------------------------

One possible downstream effector of ROQUIN--AMPK in Tfh cells is the mechanistic Target of Rapamycin (mTOR), a nutrient sensing kinase and modulator of cellular metabolism. AMPK activity directly suppresses mTORC1 signaling ([@bib25]; [@bib29]), and deletion of AMPKα1 increases mTORC1 signaling in T cells ([@bib53]). Although the role of mTOR in promoting effector CD4^+^ and CD8^+^ T cell responses is well documented ([@bib2]; [@bib8]), mTOR signaling in Tfh cell formation, and therefore antibody responses, is incompletely understood. In this respect, we assessed mTOR function in *Tringless* CD4^+^ T cells in response to TCR and CD28 stimulation. In CD4^+^ T cells, we found a reduction in phosphorylated ribosomal S6 in the absence of ROQUIN RING, indicating diminished mTORC1 function ([Figure 6a](#fig6){ref-type="fig"}). This effect was mild in naive CD44^low^ T cells but accentuated in CD44 ^high^ cells. Reflecting a role for ROQUIN RING activity during early development, abated mTOR activity was also observed in ROQUIN RING deleted primary MEFs by enhanced phosphorylation of RAPTOR Ser^792^ ([Figure 6b](#fig6){ref-type="fig"}), a target residue for AMPK-mediated inhibition.10.7554/eLife.08698.012Figure 6.ROQUIN RING signaling regulates stress granule responses to promote mTOR.(**a**) Flow cytometric analysis of phospho-rS6 Ser^235/236^ in CD44^low^ or CD44^high^ anti-CD3 and anti-CD28 stimulated CD4^+^ T cells (n = 4--6). (**b**) Phosphoblot of ACC Ser^70^ and RAPTOR Ser^792^ in primary mouse embryonic fibroblasts (MEFs) recovered in complete DMEM for 3 hr after 1 hr of 1 mM arsenite treatment (left). Quantitative ratios of phosphorylated RAPTOR to β-ACTIN input based in phosphoblot MFI readings (right). IB, immunoblot. (**c-e**) Analysis of stress granule induction in primary MEFs analyzed by fluorescence microscopy after 1 hr of 1 mM arsenite stress treatment showing counts of eIF3^+^ granules per cell (**c**), and size of individual eIF3^+^ granules in freshly arsenite-stressed primary MEFs based on area (**d**) and maximum feret (**e). (f**) Proportion of recovering primary MEFs exhibiting cytoplasmic eIF3^+^ stress granules (SG) after arsenite-mediated stress (n \>30 per time point, with each n replicate representing a single field of view displaying 1--7 adherent cells). Columns, mean; error bars, s.d. (**g**) Representative micrographs displaying recovered primary MEFs at 3 hr post-arsenite stress. Scale bar, 50 μm. Statistics were calculated by Student's t-test, n.s., not significant; \**p*\<0.05; \*\*\**p*\<0.0005. Data are representative of three independent double blind experiments. (**h**) Proportion of primary MEFs with eIF3^+^ stress granules after 1 hr of 1 mM arsenite treatment comparing wild-type and *sanroque* MEFs recovering in complete DMEM media. Data are representative of two independent experiments (n \>30 per time point, with each n replicate representing a single field of view displaying 1--6 adherent cells). Error bars, s.d. Statistics were calculated by Student's t-test, n.s., not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.012](10.7554/eLife.08698.012)10.7554/eLife.08698.013Figure 6---figure supplement 1.Stress granule sequestration of RAPTOR.(**a,b**) Colocalization of RAPTOR and eIF3^+^ stress granules in resting (**a**) and 1 mM arsenite (AS)-stressed (**b**) primary mouse embryonic fibroblasts derived from C57BL/6 timed matings. Data are representative of three independent experiments.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.013](10.7554/eLife.08698.013)10.7554/eLife.08698.014Figure 6---figure supplement 2.AMPK controls stress granule formation and maintenance.(**a**) Proportion of C57BL/6 primary mouse embryonic fibroblasts (MEFs) showing cytoplasmic eIF3^+^ stress granules (SG) immediately after cellular exposure to 1 mM arsenite (AS) for 30 min with or without 50 μM Compound C (CompC). (**b**) Proportion of primary MEFs with eIF3^+^ stress granules recovering in complete DMEM media after 1 hr of 1 mM AS treatment comparing cultures with or without 2 mM AICAR added during both AS treatment and recovery period. Data are representative of three independent experiments (n \>30 per time point, with each n replicate representing a single field of view displaying 1--6 adherent cells). Error bars, s.d. Statistics were calculated by Student's t-test, \*\*\**p*\<0.0005.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.014](10.7554/eLife.08698.014)

Stress granules are AMPK-dependent ([@bib28]; [@bib54]) cytoplasmic compartments that sequester and inactivate mTORC1 during cellular stress ([@bib84]; [@bib91]). In primary MEFs, owing to their large cytoplasm and prominent stress granules, we confirmed RAPTOR localization to eIF3^+^ stress granules in a wild-type and *Roquin^ringless^* background ([Figure 6---figure supplement 1a, b](#fig6s1){ref-type="fig"}). We also found that arsenite-induced stress granule formation was impeded by AMPK inhibition in MEFs treated with Compound C ([Figure 6---figure supplement 2a](#fig6s2){ref-type="fig"}). Therefore, we sought to determine if diminished mTOR signaling was associated with augmented stress granule formation or maintenance in ROQUIN RING-deficient cells. Analysis of arsenite-stressed primary MEFs by fluorescence microscopy revealed that loss of ROQUIN RING signaling did not alter stress granule induction ([Figure 6c--e](#fig6){ref-type="fig"}) but rather prolonged the rate of stress granule dissolution during stress recovery ([Figure 6f, g](#fig6){ref-type="fig"}). A similar delay in stress granule recovery was mirrored in primary MEFs in which AMPK activity was raised upon treatment with AICAR ([Figure 6---figure supplement 2b](#fig6s2){ref-type="fig"}). Conversely, in *sanroque* mutant primary MEFs expressing a ROQUIN variant incapable of regulating target mRNAs, we found that stress granule recovery post-arsenite treatment was comparable to wild-type MEFs ([Figure 6h](#fig6){ref-type="fig"}). Together, these data suggest that the selective Tfh cell defect in *Tringless* mice may be a result of a disrupted ROQUIN--AMPK signaling axis, otherwise important in relieving stress granule inhibition of mTOR. Furthermore, ROQUIN RING-mediated stress granule subversion of mTOR activity appears to be independent of the RNA repressive functions of the ROQUIN ROQ domain.

mTOR is required for optimal Tfh cell formation {#s2-4}
-----------------------------------------------

To determine if attenuated mTOR is associated with defective Tfh cell responses as observed in *Tringless* animals, we examined *chino* mice harboring a hypomorphic mutation (*chi* allele) in the *Frap1* gene resulting in an Ile^205^Ser substitution within the HEAT repeat domain of the mTOR protein ([Figure 7a](#fig7){ref-type="fig"}), the region dedicated to binding RAPTOR ([@bib38]). Unlike the *in utero* lethality observed in mice with complete mTOR deficiency ([@bib22]; [@bib60]), *chino* is a viable strain that exhibits growth retardation, intact thymocyte development and output but reduced phosphorylation of ribosomal protein S6 in phorbol-12-myristate-13-acetate treated peripheral CD4^+^ T cells ([@bib10]). We confirmed suboptimal phosphorylation of mTOR targets 4EBP1 and S6K in *chino* peripheral CD4^+^ T cells in response to physiological TCR activation with CD28 costimulation ([Figure 7b](#fig7){ref-type="fig"}). This was in contrast to significantly elevated FOXP3 expression. Thus, *chino*-mutant T cells represent a mild deficiency in mTOR signaling reminiscent of a partial loss-of-function in mTOR ([@bib94]) that exclusively affects extrathymic CD4^+^ T cell differentiation as seen in conditional T-cell-deleted *Frap1* knockout mice ([@bib13]). We immunized *chino* mice with SRBC, assessed the GC response 5 days later by flow cytometry and found that Tfh cells were severely diminished compared to wild-type controls ([Figure 7c](#fig7){ref-type="fig"}). This corresponded with a reduction in the GC B cell response ([Figure 7d](#fig7){ref-type="fig"}).10.7554/eLife.08698.015Figure 7.mTOR signaling is required for optimal Tfh cell formation.(**a**) *chino* mutation causes a I^205^S substitution in the mTOR protein. (**b**) Flow cytometric measurements of intracellular phospho-4EBP1 Thr^37/46^, phospho-S6K Thr^389^, and FOXP3 in CD4^+^ T cells stimulated with anti-CD3 and -CD28 for 30 min (n = 4--6). MFI, mean fluorescence intensity; column, group mean, error bars, s.d. (**c, d**) *chino* mutants were immunized with sheep red blood cells (SRBC) and taken down 5 days later to analyze the proportion of PD1^high^CXCR5^high^ Tfh cells from CD4^+^ T cells (**c**), and the proportion of GL7^high^FAS^high^ GC B cells from B220^+^ B cells (**d**) in the spleen. Data are representative of three independent experiments. Statistics were calculated by Student's t-test, \*\**p*\<0.005; \*\*\**p*\<0.0005. (**e, f**) Flow cytometric analysis 50:50 mixed LY5A wild-type:LY5B *chino* bone marrow chimeras d7 post-SRBC immunization showing the proportion of PD1^high^CXCR5^high^ Tfh cells (**e**), and expression of intracellular BCL6 (**f**) from the LY5A and LY5B CD4^+^B220^−^ T cells. Linked dot symbols, congenic cells from same animal; MFI, mean fluorescence intensity. Data are representative of two independent experiments. Statistics were calculated by Paired Student's t-test between congenically marked cells of the same animal, \**p*\<0.05.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.015](10.7554/eLife.08698.015)10.7554/eLife.08698.016Figure 7---figure supplement 1.Schematic representation of ROQUIN signaling in Tfh cell ontogeny Secondary structure of the ROQUIN protein depicting the molecular function of its distinct domains in Tfh cells.The RING zinc finger mediates autoubiquitination of ROQUIN, thereby attenuating its interacting partner AMPK which otherwise facilitates stress granule formation and maintenance, and limits both mTOR signaling and Tfh cell responses. The ROQ domain and its adjacent C3H zinc finger act in synergy to destabilize mRNA targets important in T cell activation. ROQUIN2 shares overlapping mRNA regulatory functions with ROQUIN. Pro-rich, proline rich region; 2xCoil, coiled-coil domain; AMPK, Adenosine monophosphate-activated protein kinase; Tfh cell, T follicular helper cell; mTOR, Mechanistic target of rapamycin.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.016](10.7554/eLife.08698.016)

To determine if mTOR acts within Tfh cells, we constructed and immunized 50:50 mixed wild-type:*chino* bone marrow chimeras with SRBC. At d7 post-immunization, we confirmed that the percentages of mTOR mutant PD1 ^high^CXCR5 ^high^ Tfh cells were impaired compared to their competing wild-type counterparts in the same mouse ([Figure 7e](#fig7){ref-type="fig"}). This was associated with reduced BCL6 expression intrinsic to mTOR mutant CD4^+^ T cells ([Figure 7f](#fig7){ref-type="fig"}). Our data therefore demonstrates that Tfh cells depend on intact intracellular mTOR signaling and that the *chino* Tfh-intrinsic phenotype closely mimics a defective ROQUIN RING deleted Tfh response. We therefore conclude that not only does mTOR act in the same polarity as the ROQUIN RING domain during Tfh cell development, but since mTOR signaling is a *bone fide* target of AMPK-directed inhibition ([@bib25]; [@bib29]) in CD4^+^ T cells ([@bib95]), it is most likely that mTOR represents a molecular pathway between the ROQUIN--AMPK axis and the control of Tfh responses ([Figure 7---figure supplement 1](#fig7s1){ref-type="fig"}).

Discussion {#s2-5}
----------

The critical signaling requirements specific to programming Tfh cell differentiation have been under intense investigation in the past decade ([@bib40]; [@bib71]). ROQUIN, acting through its ROQ and C3H domains, has previously been identified as a potent post-transcriptional repressor of CD4^+^ Tfh cells ([@bib24]; [@bib67]; [@bib87]; [@bib88]; [@bib92]; [@bib44]) but has also been shown to act similarly in limiting Th1, Th17 cells and CD8^+^ effector T cells ([@bib5]; [@bib31]; [@bib6]; [@bib44]). In the present study, we highlight for the first time the cellular function of the amino terminal ROQUIN RING finger and unexpectedly its importance as a positive immunomodulator of peripheral Tfh cells exclusively. In response to SRBC immunization and also to acute LCMV primary infection, mice lacking the ROQUIN RING domain in T cells failed to optimally form mature Tfh cells that could support a robust GC response. Interestingly, Th1, Th2, Th17, and Treg responses were comparable to wild-type controls *in vivo* and *in vitro*, depicting a functional uncoupling between RING signaling and ROQ-C3H activity in ROQUIN. This is consistent with our previous observations of ROQUIN RING-deficient T cells showing minimally altered expression of ICOS, a target of post-transcriptional repression ([@bib67]). We show at the molecular level, that the RING domain of ROQUIN is required to attenuate AMPK signals. In support of this finding, adenosine metabolism has previously been linked to T-dependent antibody responses in mice with observations that antigen-specific Tfh cells displayed constitutively high surface expression of CD73, an ecto-enzyme that catabolizes extracellular AMP into adenosine ([@bib30]; [@bib9]). Taken together, it is possible that Tfh cells utilize a purinergic autocrine signaling pathway similarly suggested in Treg cells ([@bib12]; [@bib76]), whereby CD73-generated adenosine external to Tfh cells is imported through nucleoside transporters for reversion back into cytoplasmic AMP by adenosine kinase, before ROQUIN RING-regulated activation of AMPK. Furthermore, since AMPK is an inhibitor of glycolysis and cellular growth ([@bib27]; [@bib59]), its activity in Tfh cells could facilitate BCL6 function, especially in transcriptionally dampening CD4^+^ T cell glycolysis ([@bib64]) which is otherwise important for cell growth ([@bib33]). This would form the basis for why Tfh cell numbers are so tightly contained throughout a GC response, acting as a critical limiting factor for controlling the magnitude and clonal diversity of GC reactions ([@bib75]; [@bib86]; [@bib71]). At first glance, it may seem conflicting that ROQUIN RING deficiency results in unrestrained AMPK leading to crippled BCL6 expression and Tfh cell hypocellularity. However, intact ROQUIN RING signaling may be advantageous, if not critical in Tfh responses, possibly acting to secure an intricate maximal threshold of AMPK activity that is key to maintaining narrow Tfh numbers for effective GC clonal selection while allowing ample, but not excessive, Tfh support to GCs.

We could not find any evidence that ROQUIN E3 ligase activity directly targets AMPK for proteosomal degradation. Instead, impaired autoubiquitination due to the absence of a functional RING domain suggests that ROQUIN E3 ligase activity can negatively regulate AMPK independent of the RNA regulatory functions of ROQUIN. Although AMPK β and γ subunits have been shown to localize to stress granules ([@bib54]), our results demonstrated an inability of the ectopically expressed regulatory subunits to localize with ROQUIN^+^ stress granules in cells also overexpressing ROQUIN, hinting at the requirement of a different cofactor for their recruitment to stress granules. Given this and the present data demonstrating the ability of ROQUIN and AMPKα1 to bind each other and colocalize within stress granules together with previous observations of stress granule exclusion of RING-deficient ROQUIN ([@bib67]), we propose a model whereby ROQUIN may be repressing AMPK activity via ubiquitin-dependent sequestration of the AMPKα1 subunit within stress granules and thereby promoting repression of AMPK kinase activity. This stress granule-associated regulation of AMPK may not be exclusive to ROQUIN but could involve other binding partners such as G3BP1, which has been shown to localize with AMPKα2 in stress granules ([@bib54]). Interestingly, a direct interaction has also been observed between AMPKα and G3BP1 ([@bib4]), an integral component of stress granules that associates with ROQUIN ([@bib24]). Analogous to the T cell anergy-regulating RING-type E3 ubiquitin ligases GRAIL and CBL-B that undergo autoubiquitination ([@bib1]; [@bib46]) as well as targeting various T cell signaling molecules for RING-mediated ubiquitination ([@bib62]; [@bib79]; [@bib80]; [@bib48]; [@bib18]; [@bib17]; [@bib32]), it is likely that ROQUIN also ubiquitinates additional proteins to coordinate Tfh cell immunity.

We found that ROQUIN RING deficiency results in intact thymic development and low phosphorylation levels of ribosomal S6 in a subset of peripheral CD4^+^ T cells, which together resembles closely *chino* mutant mice with impaired mTOR function ([@bib10]). Our data points to overactive AMPK as the link between the loss of ROQUIN RING activity and reduced mTOR signaling. As AMPK activity has been shown to be transiently upregulated within 5--20 min of stress induction and to decline after the appearance of stress granules ([@bib54]), it is possible that the subcellular sequestration of AMPK within stress granules may represent a regulatory circuit breaker to interrupt the positive feed-forward loop that acts to shut down mTOR, mRNA translation and cell growth in response to cellular stress, AMPK induction and stress granules formation. Enhanced AMPK-mediated stress granule persistence leading to mTOR repression in the absence of ROQUIN RING signaling aligns well with a report of dampened TOR activity in eukaryotic cells during cellular stress by the transient shuttling of TOR into stress granules ([@bib81]). In addition, [@bib91] also found in HeLa cells having inactivated the stress granule inhibitory kinase DYRK3, that stress granule longevity was the key to prolonging mTOR inhibition.

Since *Rc3h1* appears to be ubiquitously expressed ([@bib87]), it is intriguing that the *Tringless* allele preferentially affects Tfh cells of the GC and no other CD4^+^ T cell lineage. We found in ROQUIN RING deleted CD4^+^ T cells that this may be a result, at least in part, of insufficient IL-21 cytokine production, which is otherwise required for optimal GC reactions and to a lesser degree, Tfh cell maintenance ([@bib96]; [@bib89]; [@bib49]). IL-21 deficiency would also explain why a normal Tfh cell response with diminished GC B cells in *Tringless* mice was detected early at d6 post-SRBC immunization ([@bib67]), but both mature GC Tfh and B cell populations were crippled at d8 in the current study. Within Tfh cells, ROQUIN RING activity may also be important for transducing stimuli downstream of a GC-specific receptor such as PD1, which is uniquely found most highly expressed on the surface of Tfh cells in humans and mice ([@bib93]; [@bib34]). In CD4^+^ T cells, ligation of PD1 couples mTOR signals ([@bib21]) and also restricts cellular glycolysis ([@bib66]; [@bib65]) in a similar manner to AMPKα1 activity ([@bib53]; [@bib58]). It remains unclear how ROQUIN RING activity links to Tfh cell environmental stimuli, but there is evidence of ROQUIN phosphorylation by unknown kinases in human T cells ([@bib57]).

Previously, we showed that the *Rc3h1* '*sanroque*' allele encodes a ROQUIN^M199R^ mutant protein with a defective RNA-binding ROQ domain unable to repress ICOS. This, together with excessive IFNγ signaling causes aberrant accumulation of Tfh cells leading to unrestrained and pathogenic GC growth ([@bib44]; [@bib92]). The accumulation of Tfh cells in *sanroque* animals opposes the defective Tfh response of *Tringless* mice. We postulate that ROQUIN^133-1130^ represents a complete loss of the AMPK-regulating functions with minimal disturbance to the RNA-regulating function. This may explain why the phenotype of mice with a combined deletion of the RING domains found in both ROQUIN and that of its closely related RC3H family member ROQUIN2 ([@bib67]) is less severe than the immune deregulation of *Roquin/Roquin2* double knockout mice ([@bib88]). We have previously shown that ROQUIN2 can compensate for the RNA-regulating function of ROQUIN, both repressing overlapping mRNA targets ([@bib67]). By contrast, the *sanroque* ROQUIN^M199R^ mutated protein that can still localize to stress granules and bind RNA ([@bib3]) is likely to represent a recessive 'niche-filling' variant that selectively inactivates the normal mRNA-regulating function of ROQUIN but preserves its assembly into the mRNA decapping complex, preventing compensatory substitution by ROQUIN2 ([@bib67]). It is also likely that ROQUIN^M199R^ protein found in *sanroque* T cells retains RING finger activity to negatively regulate AMPK and promote Tfh cell development, which is compounded by the increased stability of T cell mRNAs that exacerbate Tfh accumulation and trigger autoimmunity. Indeed in mice, T cell AMPK activity has been shown to play a protective role in autoimmune models of rheumatoid arthritis and multiple sclerosis ([@bib61]; [@bib77]).

As a downstream target of AMPK metabolic signaling, mTOR is well known to orchestrate T cell effector differentiation and peripheral tolerance ([@bib8]; [@bib2]). As such, deregulation of mTOR can facilitate T-dependent autoimmune disorders like systemic lupus erythematosus ([@bib43]; [@bib20]; [@bib36]) and multiple sclerosis ([@bib14]; [@bib16]). Although active mTOR signaling in Tfh cells has been documented ([@bib23]), the specific role mTOR has in Tfh cell responses remains largely uncharacterized ([@bib2]). Our data indicate that mTOR can act in concert with and downstream of ROQUIN RING signaling to support optimal Tfh cell formation. Susceptible to both ROQUIN-controlled AMPK repression and stress granule sequestration, mTOR regulation is thus integral to Tfh cell responses. Multiple studies are also in line with this model. Similar to our findings of impaired IL-21 synthesis in mTOR-attenuated *Tringless* CD4^+^ T cells, a report on *Frap1* knockout T cells cultured *in vitro* also displayed reduced expression of IL-21 ([@bib13]). Moreover, low expression and secretion of IL-21 was observed in rapamycin-treated human CD4^+^ T cells polarised toward the Tfh cell lineage *ex vivo* ([@bib11]). Also in mice with reduced mTOR, T-dependent B cell proliferation, isotype switching, GC formation and antigen-specific antibody responses were significantly crippled ([@bib94]; [@bib37]). Additional *in vivo* studies, however, are required to dissect the downstream signals transduced by mTOR that orchestrate Tfh immune responses. Thorough investigation of these and similar metabolic pathways including AMPK-dependent cellular bioenergetics within Tfh cells and in other GC T cell subsets ([@bib69]) is not only warranted but also may advance current strategies for vaccine design or reveal novel therapeutic interventions for antibody-mediated immune disorders.

Materials and methods {#s3}
=====================

Mice {#s3-1}
----

ROQUIN RING deleted mice ([@bib67]) were generated by Ozgene, Australia; *loxP* sites that flanked or 'floxed' *Rc3h1 *exon 2, encoding the START codon and RING motif ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}), were inserted into C57BL/6 mouse embryonic stem (ES) cells via homologous recombination . Recombinant ES cell clones were implanted into C57BL/6 foster mothers. Heterozygote progeny were screened for germline transmission before crossing to *Rosa26:Flp1* mice to remove the *neo* cassette. Mice harboring the floxed *Rc3h1* allele (*Rc3h1^lox/+^*) were then crossed to *Rosa26:Cre* knock-in mice for one generation. Removal of Cre expression was then achieved by a C57BL/6 backcross yielding a germline deletion of *Rc3h1* exon 2. This strain was named *ringless (rin* allele). A conditional ROQUIN RING-deficient strain (called *Tringless*) was also generated by crossing *Rc3h1^lox/lox^*mice to *Lck:*Cre breeders to remove *Rc3h1* exon 2 specifically in T lymphocytes (*Trin* allele). Upon Cre-mediated excision of *Rc3h1* exon 2, rescue of in-frame protein synthesis at Met^133^ is expected to produce an E3 ligase defective ROQUIN mutant. *Rosa26:Cre* and *Lck:Cre* mice were maintained on a C57BL/6 background with one copy of the Cre transgene and provided by Ozgene, Australia. ENU-derived *chino* mutants were previously characterized ([@bib10]). To generate mixed bone marrow chimeric mice, recipient *Rag1^-/-^* mice were sublethally irradiated and reconstituted i.v. with 2 x 10^6^ bone marrow hematopoietic stem cells.

Animal experiments were approved by the Animal Experimentation Ethics Committee of the Australian National University (Protocols J. IG.71.08, A2012/05 and A2012/53) and the McGill University Ethics Committee (Protocol 7259). Mice were maintained in a specific germ-free environment. Where indicated, 8 to 12 wo mice were immunized i.p. with 2 x 10^9^ SRBC to generate a T-dependent GC response or i.p. with 2 x 10^5^ PFU of LCMV Armstrong.

Molecular reagents {#s3-2}
------------------

The following antibodies were used in Western blots, immunoprecipitation assays and fluorescence microscopy: rabbit anti-phospho-ACC Ser^79^ (Cat. 3661, Cell Signaling), rabbit phospho-RAPTOR Ser^792^ (Cat. 2083, Cell Signaling), rabbit anti- β-ACTIN (13E5, Cell Signaling), rabbit anti-AMPKα (Cat. ab32047, Abcam, UK), goat anti-eIF3 (N-20, Santa Cruz), mouse anti-GFP (7.1 and 13.1, Roche), rabbit anti-GFP (Cat. ab290, Abcam), mouse anti-HA (HA-7, Sigma-Aldrich), rabbit anti-HA (H6908, Sigma-Aldrich), rabbit anti-RAPTOR (24C12, Cell Signaling), rabbit anti-ROQUIN (Cat. A300-514A, Bethyl Laboratories), mouse anti-UBIQUITIN (P4D1, Cell Signaling), mouse anti-V5 (V5-10, Sigma-Aldrich), rabbit anti-V5 (Cat. V8137, Sigma- Aldrich), mouse anti-rabbit IgG light chain (211-032-171, Jackson ImmunoResearch), and goat anti-mouse IgG light chain (155-035-174, Jackson ImmunoResearch). AICAR (Calbiochem) and Compound C (Calbiochem) were used according to manufacturers' recommendations at indicated concentrations. N-terminal V5 tagged full length ROQUIN and ROQUIN^133-1130^ constructs have been previously described ([@bib67]). C-terminal GFP fused ROQUIN and ROQUIN^C14A^ constructs have previously been described ([@bib3]). GFP tagged constructs of AMPK subunits were obtained from Origene. HEK293T and EL4 cells were obtained from the ATCC and perpetuated in-house. Primary MEFs were harvested from E14 fetuses of *rin/+* or *san/+* pregnant females that were paired with *rin/+* or *san/+* males, respectively, as part of a timed mating.

T cell stimulation, flow cytometry, and immunofluorescence {#s3-3}
----------------------------------------------------------

Where indicated *in vitro* stimulation of T cells was performed using anti-CD3 and anti-CD28 dual coated Dynabeads (Invitrogen) or for cytokine accumulation, phorbol myristate acetate (Sigma-Aldrich), and ionomycin (Sigma-Aldrich) was used with GolgiStop (BD Biosciences) in RPMI 1640 medium (Invitrogen) supplemented with 2 mM l-glutamine (Invitrogen), 100 U penicillin-streptomycin (Invitrogen), 0.1 mM non-essential amino acids (Invitrogen), 100 mM HEPES (Sigma-Aldrich), 0.0055 mM 2-mercaptoethanol, and 10% FCS. 20 ng/mL IL-2 (R&D Systems), 100 ng/mL IL-4 (Miltenyi Biotec), 100 ng/mL IL-6 (Peprotech), 20 ng/mL IL-12 (Miltenyi Biotec), 1 ng/mL TGFβ (R&D Systems), along with 1μg/mL of Biolegend antibodies anti-IL-4, anti-IFNγ and/or anti-IL-12 were used for *in vitro* polarization of (IL-2) Th0, (IL-2, IL-12, and anti-IL-4) Th1, (IL-2, IL-4, anti-IFNγ, and anti-IL-12) Th2, (IL-2, IL-6, TGFβ, anti-IL-4, and anti-IFNγ) Th17, and (IL-2 and TGFβ) iTreg cultures. To stain surface markers, cells were washed and stained in ice-cold staining buffer (2% FCS, 0.1% NaN~3~ in PBS). eBioscience FOXP3 Staining Buffer Set was used for flow cytometric detection of intracellular proteins. Data were acquired by a LSRII Flow Cytometer using FACSDiva software. MEFs and HEK293T cells were prepared for fluorescence microscopy as previously described ([@bib3]). Images were collected using an Olympus IX71 microscope with DP Controller software (Olympus).

AMPK kinase assay in CD4^+^ T cells {#s3-4}
-----------------------------------

CD4^+^ T cells were isolated from *floxed* wild-type or *Tringless* mice by MACS Microbead separation (Miltenyi Biotec). AMPK activity was measured from AMPK complexes immunoprecipitated from cell lysates using anti-AMPKα antibody (Abcam) as previously described ([@bib7]). Detection of ACC Ser^79^ phosphorylation levels was also used to measure AMPK allosteric activity.

Immunoprecipitation and Western blotting {#s3-5}
----------------------------------------

Whole-cell lysates were prepared using TNE lysis buffer (1% NP40, 150 mM NaCl, 20 mM Tris-base, 1 mM EDTA and Roche cOmplete EDTA-free protease inhibitory cocktail tablets all dissolved in water). PhosSTOP (Roche) was added to the TNE mix for the detection of phospho-residues. To immunoprecipitate proteins, antibody was added to pre-cleared lysates and mixed with Protein G Sepharose 4 Fast Flow (GE Healthcare) for 12 hr then washed. For western blotting, lysates were separated by SDS-PAGE, transferred to nitrocellulose membrane, blocked in 5% BSA Tris-buffered saline containing 0.05% Tween-20, probed with primary antibodies and detected with horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies.

Proximity ligation assays {#s3-6}
-------------------------

MEFs were seeded on coverslips and prepared as described previously ([@bib78]). To induce cellular stress, 1 mM arsenite was added to cultures for 1 hr. Stains with primary antibodies were carried out using optimized conditions overnight at 4°C in a humid chamber. The primary antibodies were goat anit-AMPKα1, clone C20 (Santa Cruz) at 1:75 ; with either rabbit anti-ROQUIN at 1:75 (Cat. NB100-655, Novus Biologicals) or rabbit anti-GFP 1:1000 (Cat. ab6556, Abcam, UK). Images were taken on a Leica SP5 confocal microscope with a pin hole of 67.9 μm and an APO CS 1.25 UV x40 oil objective. Higher magnification images presented in [Figure 3c](#fig3){ref-type="fig"} were taken on a Leica SP5 confocal microscope with a pin-hole of 95.5 μm and an HCxPL APO lambda blue x63/1.4 oil objective.

*In vitro* autoubiquitination assays {#s3-7}
------------------------------------

Mouse UBCH5A (E2) was expressed as a GST-fusion protein and purified using standard protocols. ROQUIN constructs were also expressed as GST-fusion proteins using standard procedures except that 0.1 mM Zn-acetate was added to the growth media and all purification buffers. Human E1 (His~6~ tagged) was purchased from Biomol International. Bovine UBIQUITIN was purchased from Sigma-Aldrich. Ubiquitination assays were performed in 20 ml in 20 mM Tris-HCl, 50 mM NaCl, 2 mM MgCl~2~, 1 mM ATP, 0.1 mM DTT at 25^o^C. Reactions were stopped by the addition of 2x SDS PAGE loading buffer and heating at 95^o^C for 5 min and analyzed by SDS-PAGE and Coomassie Blue staining. Typically reactions contained 0.1 mM E1, 10 mM E2, 50 mM UBIQUITIN, and 0.5 mg/mL ROQUIN peptide.

*In silico* analysis {#s3-8}
--------------------

Statistics were calculated using Prism 5.0a software (GraphPad). Stress granule morphology and PLAs were assessed by ImageJ 1.46r software (NIH).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for submitting your work entitled \"Attenuation of AMPK signaling by ROQUIN promotes formation of T follicular helper cells\" for peer review at *eLife*. Your submission has been favorably evaluated by Tadatsugu Taniguchi (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. One of the three peer reviewers, Masato Kubo, has agreed to reveal his identity.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The post-transcriptional repressor ROQUIN has previously been demonstrated to have a critical role in the negative regulation of Tfh cells as *sanroque* mice with a dominant negative ROQUIN mutation or T cell-specific deletion of ROQUIN and its paralogue ROQUIN2 leads to unrestrained formation of Tfh. The authors here investigate the effect of specific depletion of the RING domain of ROQUIN and unexpectedly find that this domain has a positive role in Tfh formation in contrast to the overall negative role of ROQUIN. They describe that this loss of Tfh formation and function is due to loss of ROQUIN RING dependent antagonism of AMPK which in turn causes loss of mTOR function that, through largely unknown mechanisms, inhibits Tfh formation.

Major comments:

1\) In [Figure 7](#fig7){ref-type="fig"}, Foxp3 MFI rose in the *chino* mutants. As the authors of this paper have previously demonstrated CD4^+^PD1^+^CXCR5^+^ cells are made up of a mixture of Foxp3- Tfh and FOXP3^+^ Tfr cells. A rise in the MFI of Foxp3 fails to determine if this is Foxp3 expression being induced by Tfh or, as seems more likely, a change in the proportion of Foxp3 expressing Tfr cells within the \"Tfh\" gate. Since Tfh and Tfr are distinct populations it would be better to more clearly divide the population into Foxp3- Tfh and FOXP3^+^ Tfr and showing this both by representative gating and including a graph of % Foxp3 within \"Tfh\" or similar method. It is important that the authors have demonstrated in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} that Thymic Treg formation and Treg levels in the periphery are not significantly altered in *Trin/Trin* mice. However this does not fully address the question of Tfr formation as we do not understand the role of *Trin* in Tfr. In much the same way that looking at total CD4 cells would not have revealed the effects on Tfh looking at total Tregs will not reveal any Tfr specific effects. Given the known role of mTOR inhibitors such as rapamycin in enhancing Treg numbers and the data in [Figure 7e](#fig7){ref-type="fig"}, it is plausible that the Tfh/Tfr ratio may be altered. Addressing this point will both strengthen the conclusions on Tfh (by confirming what percentage of them are actually Tfh) and add impact by widening the results to include or exclude an effect on Tfr. This issue can be quickly and simply addressed by including some indication of the percentage of Foxp3 expression within the PD1^+^CXCR5^+^ population Tfh in [Figures 1](#fig1){ref-type="fig"} and [7](#fig7){ref-type="fig"}. Presumably the data in [Figure 7](#fig7){ref-type="fig"} is already available and simply requires reanalysis while [Figure 1](#fig1){ref-type="fig"} may require a further experiment.

2\) Are these mice the same *Roquin1 ringless* mice previously used in Pratama et al. Immunity 2013? If so this could be referenced more clearly in the Methods section as the previous paper also described these mice to some extent. Of note in Pratama et al. 2013 it was shown in [Figure 4a](#fig4){ref-type="fig"} that *Trin/Trin Lck:Cre* mice had reduced GC formation and a trend towards reduced Tfh formation following SRBC vaccination. That is essentially the same experiment as seen here in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}. It would be harsh to suggest that this affects novelty, since the previous paper did not focus on this issue and the current paper goes into far more detail. Nonetheless the authors should more clearly clarify this work in its relation to previously published work by noting this previous finding.

3\) [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} address the ROQUIN-mediated mTOR attenuation cause specific defect in Tfh during LCMV infection, and [Figure 7](#fig7){ref-type="fig"} indicated that hypomorphic mutation mice of the *Frap1* gene also had the same phenotype. However, previous reports have suggested that mTOR signals are also required for Th1, Th17, and Th2 differentiation (Kopf et al. 2007 Int. Immunopharmacol.; Delgoffe et al. 2009 Immunology; Delgoffe et al. 2011 Nat. Imunol.). I understand that different lineages have different requirements in mTOR signal. To strengthen their hypothesis, the authors need a more mechanistic explanation why the defect of RING domain loss appeared only in the Tfh program.

4\) The manuscript does very well at describing how the ROQUIN-AMPK-mTOR axis controls the expression of several key genes involved in the Tfh program, CXCR5 and *Bcl6*. It raises the question of how the ROQUIN-AMPK-mTOR axis controls the expression of CXCR5 and *Bcl6* and what is a target of this pathway. It is recommended that the authors show transcriptome data of TFH cells in the ROQUIN RING loss mice and the hypomorphic mutant mice of the *Frap1* gene and compare.

5\) The FACS profile indicating GC-B in the hypomorphic mutant mice of the *Frap1* gene is clearly different from that in the ROQUIN RING loss mice ([Figure 1d](#fig1){ref-type="fig"}). We hope you can show the impact on humoral responses, because TFH and GC-B cell development is not convincing enough to prove the impact in humoral responses. It is recommended they show the antibody responses in the response to LCMV.

6\) The finding that the effects seen are independent of *Roquin\'s* RNA binding activity and its recruitment of the CCR4-NOT complex to RNA targets is particularly interesting. Nonetheless, some aspects of the data provided are not entirely compelling. Both proteins, ROQUIN and AMPKα1, colocalize but the association as measured by co-immunoprecipitation, seems quite inefficient. The authors should consider being more circumspect in this conclusion and allow for the possibility that the interactions are indirect. Also, some of the lanes shown in [Figure 4](#fig4){ref-type="fig"} are so overexposed that it is not clear what they add. Other blots are severely cropped -- such blots are less convincing. In addition, it would seem that showing the control of a mutant with abrogation of the RNA binding could be useful in the stress granule assays.

7\) The main data demonstrating an alteration in mTOR signaling in *Trin* mice is presented in [Figure 6a](#fig6){ref-type="fig"}. Showing the primary data for a selected experiment (i.e. histograms of pS6) would be more convincing. More evidence supporting this conclusion would strengthen the authors\' argument.

8\) The authors suggest that this effect seen is specific to Tfh cells. This may be the case; however, their investigation into alternate T cell subsets is limited. *In vitro* Th1, Th2, Th17, and iTreg differentiation would be the minimum exploration using the *Trin* mice, and it would be additionally helpful to explore antigen specific Th1 differentiation in LCMV ([Figure 2](#fig2){ref-type="fig"}, add tetramer+ Th1 cells). Additionally, exploration of these cell types in the *chi/chi* model would be helpful to confirm that this is truly specific to Tfh cell differentiation. An additional angle that is lacking is the role of *Roquin2* in compensating for *Roquin1*. Previous work from this group has shown that *Roquin2* can compensate for *Roquin1*. Do doubly deficient *Roquin1/Roquin2* mice have a more severe defect in Tfh differentiation, or does it extend beyond Tfh cells? Are there circumstances in which compensation is more relevant? *Roquin* appears to be broadly expressed and the formation of stress granules is also not cell-type specific (and presumably will require AMPK for efficient resolving/modulation of TOR). Better explanation of why Tfh cells are selectively affected is in order.

10.7554/eLife.08698.021

Author response

*Major comments:1) In [Figure 7](#fig7){ref-type="fig"}, Foxp3 MFI rose in the chino mutants. As the authors of this paper have previously demonstrated CD4^+^PD1^+^CXCR5^+^cells are made up of a mixture of Foxp3- Tfh and FOXP3^+^ Tfr cells. A rise in the MFI of Foxp3 fails to determine if this is Foxp3 expression being induced by Tfh or, as seems more likely, a change in the proportion of Foxp3 expressing Tfr cells within the \"Tfh\" gate. Since Tfh and Tfr are distinct populations it would be better to more clearly divide the population into Foxp3- Tfh and FOXP3^+^ Tfrand showing this both by representative gating and including a graph of% Foxp3 within \"Tfh\" or similar method. It is important that the authors have demonstrated in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"} that Thymic Treg formation and Treg levels in the periphery are not significantly altered in Trin/Trin mice. However this does not fully address the question of Tfr formation as we do not understand the role of Trin in Tfr. In much the same way that looking at total CD4 cells would not have revealed the effects on Tfh looking at total Tregs will not reveal any Tfr specific effects. Given the known role of mTOR inhibitors such as rapamycin in enhancing Treg numbers and the data in [Figure 7e](#fig7){ref-type="fig"}, it is plausible that the Tfh/Tfr ratio may be altered. Addressing this point will both strengthen the conclusions on Tfh (by confirming what percentage of them are actually Tfh) and add impact by widening the results to include or exclude an effect on Tfr. This issue can be quickly and simply addressed by including some indication of the percentage of Foxp3 expression within the PD1^+^CXCR5^+^ population Tfh in [Figures 1](#fig1){ref-type="fig"} and 7. Presumably the data in [Figure 7](#fig7){ref-type="fig"} is already available and simply requires reanalysis while [Figure 1](#fig1){ref-type="fig"} may require a further experiment.*

We and others (Ramiscal and Vinuesa, 2013 *Immunological Reviews*; Sage et al. 2013 *Nature Immunology*; Ding et al. 2014 *Arthritis and Rheumatology*) have proposed that compared to the conventional CD4^+^PD1^+^CXCR5^+^ total "Tfh gate", the evaluation of distinct subsets within this total Tfh population, especially the ratio between FOXP3^-^ effector Tfh cells and their FOXP3 expressing suppressive Tfr counterparts may serve as an important tool for projecting the magnitude and robustness of T-dependent antibody responses and GC reactions. Considering that Tfr cells are a relatively new T cell subset, incompletely understood and their thymic origin differing from the peripheral development of effector Tfh cells, we are cautious in explicitly associating Tfr differentiation with ROQUIN RING signaling since arguing for this case would extend beyond the focus of the present study and would require further extensive investigation. Nonetheless, *Tringless* show an augmented population of FOXP3^+^ Tfr cells at the expense of effector Tfh cells (new [Figure 2h](#fig2){ref-type="fig"}), both subsets likely competing for a shared GC niche. This trend is also reflected in immunized *chino* mice (data not published).

*2) Are these mice the same Roquin1 ringless mice previously used in Pratama* et al. *Immunity 2013? If so this could be referenced more clearly in the Methods section as the previous paper also described these mice to some extent. Of note in Pratama* et al*. 2013 it was shown that Trin/Trin Lck:Cre mice had reduced GC formation and a trend towards reduced Tfh formation following SRBC vaccination. That is essentially the same experiment as seen here in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}. It would be harsh to suggest that this affects novelty, since the previous paper did not focus on this issue and the current paper goes into far more detail. Nonetheless the authors should more clearly clarify this work in its relation to previously published work by noting this previous finding.*

The *Lck:Cre ringless* mice in our 2013 *Immunity* report are indeed the same as the *Rc3h1 Tringless* mice presented in the current study. The former case depicts early Tfh percentages at d6 post-SRBC immunization. In contrast, the present study provides a d8 FACS analysis of mature Tfh responses to SRBC immunization in *Tringless*. This d8 Tfh response is reconciled with the findings in [Figure 1](#fig1){ref-type="fig"} and [Figure 2](#fig2){ref-type="fig"} showing Tfh responses to LCMV d10 post-infection. Based on our previous examination on the influence of IL-21 cytokine in SRBC-responsive Tfh responses (Linterman et al., 2010 *Journal of Experimental Medicine*), it is evident that IL-21 deficiency may begin to destabilize Tfh formation and GC reactions at d8 post-immunization but not on d6. We have included additional data (new [Figure 2a](#fig2){ref-type="fig"}) demonstrating that *Tringless* CD4^+^ T cells produce less IL-21, and this may, at least in part, provide some insight into the different Tfh percentages detected in *Tringless* mice at d6 versus d8 post-SRBC injection. As advised by the reviewers, we have endeavored to more clearly relate the present study to our previously published Pratama et al. (2013, *Immunity*) findings (citation in Materials and methods, Mice section and new text in the Introduction, last paragraph).

*3) [Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"} address the ROQUIN-mediated mTOR attenuation cause specific defect in Tfh during LCMV infection, and [Figure 7](#fig7){ref-type="fig"} indicated that hypomorphic mutation mice of the Frap1 gene also had the same phenotype. However, previous reports have suggested that mTOR signals are also required for Th1, Th17, and Th2 differentiation (Kopf et al. 2007 Int. Immunopharmacol.; Delgoffe et al. 2009 Immunology; Delgoffe et al. 2011 Nat. Imunol.). I understand that different lineages have different requirements in mTOR signal. To strengthen their hypothesis, the authors need a more mechanistic explanation why the defect of RING domain loss appeared only in the Tfh program.*

We have now proposed a more in-depth model for why ROQUIN RING activity is specifically affecting Tfh cell responses (Discussion, fourth paragraph). We postulate that reduced IL-21 production and maybe deregulated PD1 signal transduction may be factors in the Tfh-specific phenotype of immunized *Tringless* mice.

*4) The manuscript does very well at describing how the ROQUIN-AMPK-mTOR axis controls the expression of several key genes involved in the Tfh program, CXCR5 and Bcl6. It raises the question of how the ROQUIN-AMPK-mTOR axis controls the expression of CXCR5 and Bcl6 and what is a target of this pathway. It is recommended that the authors show transcriptome data of TFH cells in the ROQUIN RING loss mice and the hypomorphic mutant mice of the Frap1 gene and compare.*

As advised by the reviewers, we attempted to FACS sort Tfh cells from both SRBC-immunized *Tringless* and *chino* mice but were unable to obtain enough Tfh cells for quality RNA input for transcriptome analysis. In our hands, it is not feasible to sufficiently sort Tfh cells from GC-immunodeficient mice such as these. However, we have identified a deficiency in T cell production of the GC-specific cytokine IL-21 in immunized *Tringless* mice (new [Figure 2a](#fig2){ref-type="fig"}). IL-21 expression is known to be mTOR-dependent *in vivo* and *in vitro* as noted by published reports, which are cited in the Discussion section (last paragraph).

*5) The FACS profile indicating GC-B in the hypomorphic mutant mice of the Frap1 gene is clearly different from that in the ROQUIN RING loss mice ([Figure 1d](#fig1){ref-type="fig"}). We hope you can show the impact on humoral responses, because TFH and GC-B cell development is not convincing enough to prove the impact in humoral responses. It is recommended they show the antibody responses in the response to LCMV.*

We agree with the reviewers' observation and note the distinct GC B cell responses in the two mouse models examined in our study. One explanation for the varied GC reactions in *Tringless* versus the *chino* strain is that in *Tringless* mice, all B cells are ROQUIN RING sufficient but dependent on ROQUIN RING-deleted T cell help, whereas in *chino* animals, defective mTOR signaling is intrinsic not only to T cells but also B cells since all germline cells are mutated. Zhang et al. (2014) has previously outlined an important B cell-intrinsic role for mTOR in GC reactions in response to various T-dependent antigens. Nonetheless, as suggested we have performed an ELISA assay to measure anti-LCMV IgG and as expected found no significant differences in antibody titres between *Tringless* and floxed wild-type animals at d10 post-viral infection ([Author response image 1](#fig8){ref-type="fig"}). Similar findings have also been reported in Tfh-deficient CXCR5 KO (Fahey et al. 2011, *Journal of Experimental Medicine*) and SAP KO (Crotty et al. 2003, *Nature*) mice infected with LCMV and examined 10 d later. This is because early antibody responses to primary infection are predominantly derived from short-lived extrafollicular responses and less dependent on GC reactions which tend to play a critical role in the generation of affinity-matured long-term antibody responses and most importantly in seeding memory B cells for secondary recall antibody production. As such, with multiple older studies demonstrating Tfh-independent early anti-viral antibody responses, we believe addition of our data showing *Tringless* early IgG responses being intact at d10 post-infection will not add significant novelty nor dimension to our study.10.7554/eLife.08698.017Author response image 1.*Tringless* mice inoculated with LCMV and sera collected d10 post-infection to measure the anti-LCMV specific IgG response. n.s., not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.08698.017](10.7554/eLife.08698.017)

*6) The finding that the effects seen are independent of Roquin\'s RNA binding activity and its recruitment of the CCR4-NOT complex to RNA targets is particularly interesting. Nonetheless, some aspects of the data provided are not entirely compelling. Both proteins, Roquin and AMPKα1, colocalize but the association as measured by co-immunoprecipitation, seems quite inefficient. The authors should consider being more circumspect in this conclusion and allow for the possibility that the interactions are indirect. Also, some of the lanes shown in [Figure 4](#fig4){ref-type="fig"} are so overexposed that it is not clear what they add. Other blots are severely cropped -- such blots are less convincing. In addition, it would seem that showing the control of a mutant with abrogation of the RNA binding could be useful in the stress granule assays.*

We agree with the reviewers' comments that the immunoprecipitation assays do not exclude the possibility that the ROQUIN-AMPKα1 interaction is indirect. We therefore performed an *in situ* proximity ligation assay (PLA), which detects interacting proteins that are in close proximity, within 30-40 nm of each other, and allows for a quantitative analysis of these interactions. Our PLA results indicate that ROQUIN and AMPKα1 endogenous proteins in primary C57BL/6 mouse embryonic fibroblasts (MEFs) are close binding partners (new [Figure 3c, d](#fig3){ref-type="fig"}). In [Figure 4](#fig4){ref-type="fig"}, we agree that the over-expressed lanes may not significantly add to the data as intended and thus they have been removed (new [Figure 4](#fig4){ref-type="fig"}). We have also expanded the size of cropped western blot images to show more length in the lanes. Additionally, as suggested by the reviewers we performed stress granule recovery assays of *sanroque* MEFs which express the ROQUIN^M199R^ mutant protein with a dysfunctional ROQ domain incapable of repressing mRNA. We found that *sanroque* MEFs recovered as efficiently from arsenite-induced cellular stress as wild-type MEFs (new [Figure 6h](#fig6){ref-type="fig"}). This is in contrast to the *ringless* MEFs which display a significant lag during stress granule recovery. These results further highlight a ROQUIN RING functional divergence from ROQ-mediated RNA metabolism.

*7) The main data demonstrating an alteration in mTOR signaling in Trin mice is presented in [Figure 6a](#fig6){ref-type="fig"}. Showing the primary data for a selected experiment (i.e. histograms of pS6) would be more convincing. More evidence supporting this conclusion would strengthen the authors\' argument.*

As requested by the reviewers, we have now replaced our line graph of p-S6 with its histogram and have added extra data to show p-S6 data in Tnaive CD44^low^ cells as well as antigen-experienced CD44^high^ cells (new [Figure 6a](#fig6){ref-type="fig"}). Furthermore, we have also included data demonstrating that mTOR-dependent IL-21 cytokine production is impaired in immunized *Tringless* mice (new [Figure 2a](#fig2){ref-type="fig"}).

*8) The authors suggest that this effect seen is specific to Tfh cells. This may be the case; however, their investigation into alternate T cell subsets is limited. In vitro Th1, Th2, Th17, and iTreg differentiation would be the minimum exploration using the Trin mice, and it would be additionally helpful to explore antigen specific Th1 differentiation in LCMV ([Figure 2](#fig2){ref-type="fig"}, add tetramer+ Th1 cells). Additionally, exploration of these cell types in the chi/chi model would be helpful to confirm that this is truly specific to Tfh cell differentiation. An additional angle that is lacking is the role of Roquin2 in compensating for Roquin1. Previous work from this group has shown that Roquin2 can compensate for Roquin1. Do doubly deficient Roquin1/Roquin2 mice have a more severe defect in Tfh differentiation, or does it extend beyond Tfh cells? Are there circumstances in which compensation is more relevant? Roquin appears to be broadly expressed and the formation of stress granules is also not cell-type specific (and presumably will require AMPK for efficient resolving/modulation of TOR). Better explanation of why Tfh cells are selectively affected is in order.*

We have examined T cell cultures from sorted CD4^+^ naive T cells to look at the influence of ROQUIN RING deficiency in the differentiation of Th1, Th2, Th17 and iTreg cells *in vitro* (new [Figure 1---figure supplement 2h, i](#fig1s2){ref-type="fig"}). Our new data demonstrate that the expression of nuclear factors required for non-follicular effector T cell development in the periphery, namely TBET, GATA3, RORγT and FOXP3 in activated CD4^+^ T cell cultures are comparable to wild-type cells. This is consistent with our *in vivo* findings in mice immunized with SRBC or infected with LCMV. It is not likely that *chino* mice display a Tfh-specific defect as observed in *Tringless* animals since *chino* T cells represent a ROQUIN-indepedent mTOR defect and display a widespread inability to generate and/or sustain a CD44^high^ effector and memory T cell compartment (Daley et al. Elife, 2013). It is possible that ROQUIN RING signaling acts as a signal transducer of a Tfh-specific signal such as PD1, FR4 or CD73 found highly expressed on the surface of Tfh cells, to control mTOR signals.

Regarding the question of whether doubly deficient *Roquin1/Roquin2* mice have a more severe defect in Tfh differentiation, we showed in Pratama et al. *Immunity* (2013) that the Tfh defect observed in *Roquin1 ringless* mice is not seen in *Roquin2 ringless* and that double ROQUIN1/2 RING deficiency in fact corrects the *Roquin1 ringless* Tfh defect. These results suggest that ROQUIN2 does not target AMPK in Tfh cell responses, and additional targets may play opposing roles on Tfh cells, but elucidation of the relevant ROQUIN2 actions to explain this effect we believe are beyond the scope of the current manuscript.

As advised, we have included the tetramer^+^ Th1 cell response of LCMV-infected *Tringless* mice ([Figure 2b](#fig2){ref-type="fig"}, [c](#fig2){ref-type="fig"}) showing no abnormalities when compared to wild-type floxed controls. These observations of virus-specific Th1 cells are in line with intact total Th1 responses ([Figure 1a](#fig1){ref-type="fig"}).

[^1]: These authors contributed equally to this work.
